Microsatellite and EGFR, HER2 and K-RAS analyses in sclerosing hemangioma of the lung

Giuliana Sartori, Stefania Bettelli, Laura Schirosi, Nazzarena Bigiani, Antonio Maiorana, Alberto Cavazza, Giulio Rossi

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Sclerosing hemangioma (SH) is an uncommon pulmonary tumor thought to derive from primitive respiratory epithelium consisting of 2 cell populations (cuboidal surface and polygonal stromal cells) and sharing some clinical characteristics (frequent occurrence in nonsmoking women of Asian ethnicity) with bronchioloalveolar carcinoma with which it has been suggested a possible common origin. We investigated 11 cases of SH by immunohistochemistry, fluorescence in situ hybridization, and polymerase chain reaction-based microsatellite and mutational analyses with particular emphasis on possible alterations of microsatellite loci located at tumor suppressor genes (FHIT, p16, Rb, and p53) involved in lung adenocarcinoma genesis and EGFR, HER2, and K-RAS genes. Although EGFR expression was observed in all tested cases, none showed HER2 immunostaining. Fluorescence in situ hybridization and mutational analysis of EGFR and HER2 and also K-RAS sequencing did not reveal molecular alterations, whereas allelic losses at p16 and Rb loci (4 and 2 out of 9 tested cases, respectively) with an identical microsatellite allelic loss pattern in both cuboidal and polygonal cells were observed. The finding of microsatellite alterations in chromosomal regions related to genes deeply involved in early stage lung adenocarcinoma could suggest a possible link between SH and bronchioloalveolar carcinoma, but tumor pathway promoted by EGFR, HER2, and K-RAS does not represent a common molecular mechanism of tumorigenesis. Microsatellite alterations identified in cuboidal and polygonal cells further confirm the clonal and neoplastic nature of both components of SH.

Original languageEnglish
Pages (from-to)1512-1520
Number of pages9
JournalAmerican Journal of Surgical Pathology
Volume31
Issue number10
DOIs
Publication statusPublished - Oct 2007

Fingerprint

Pulmonary Sclerosing Hemangioma
Benign Fibrous Histiocytoma
Microsatellite Repeats
Bronchiolo-Alveolar Adenocarcinoma
Loss of Heterozygosity
Fluorescence In Situ Hybridization
Respiratory Mucosa
Stromal Cells
Tumor Suppressor Genes
Genes
Neoplasms
Carcinogenesis
Immunohistochemistry
Polymerase Chain Reaction
Lung
Population

Keywords

  • EGFR
  • K-RAS
  • LOH
  • Lung
  • Sclerosing hemangioma

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine

Cite this

Microsatellite and EGFR, HER2 and K-RAS analyses in sclerosing hemangioma of the lung. / Sartori, Giuliana; Bettelli, Stefania; Schirosi, Laura; Bigiani, Nazzarena; Maiorana, Antonio; Cavazza, Alberto; Rossi, Giulio.

In: American Journal of Surgical Pathology, Vol. 31, No. 10, 10.2007, p. 1512-1520.

Research output: Contribution to journalArticle

Sartori, Giuliana ; Bettelli, Stefania ; Schirosi, Laura ; Bigiani, Nazzarena ; Maiorana, Antonio ; Cavazza, Alberto ; Rossi, Giulio. / Microsatellite and EGFR, HER2 and K-RAS analyses in sclerosing hemangioma of the lung. In: American Journal of Surgical Pathology. 2007 ; Vol. 31, No. 10. pp. 1512-1520.
@article{d1b8170dd4c14b3e8ad6db2789d44d02,
title = "Microsatellite and EGFR, HER2 and K-RAS analyses in sclerosing hemangioma of the lung",
abstract = "Sclerosing hemangioma (SH) is an uncommon pulmonary tumor thought to derive from primitive respiratory epithelium consisting of 2 cell populations (cuboidal surface and polygonal stromal cells) and sharing some clinical characteristics (frequent occurrence in nonsmoking women of Asian ethnicity) with bronchioloalveolar carcinoma with which it has been suggested a possible common origin. We investigated 11 cases of SH by immunohistochemistry, fluorescence in situ hybridization, and polymerase chain reaction-based microsatellite and mutational analyses with particular emphasis on possible alterations of microsatellite loci located at tumor suppressor genes (FHIT, p16, Rb, and p53) involved in lung adenocarcinoma genesis and EGFR, HER2, and K-RAS genes. Although EGFR expression was observed in all tested cases, none showed HER2 immunostaining. Fluorescence in situ hybridization and mutational analysis of EGFR and HER2 and also K-RAS sequencing did not reveal molecular alterations, whereas allelic losses at p16 and Rb loci (4 and 2 out of 9 tested cases, respectively) with an identical microsatellite allelic loss pattern in both cuboidal and polygonal cells were observed. The finding of microsatellite alterations in chromosomal regions related to genes deeply involved in early stage lung adenocarcinoma could suggest a possible link between SH and bronchioloalveolar carcinoma, but tumor pathway promoted by EGFR, HER2, and K-RAS does not represent a common molecular mechanism of tumorigenesis. Microsatellite alterations identified in cuboidal and polygonal cells further confirm the clonal and neoplastic nature of both components of SH.",
keywords = "EGFR, K-RAS, LOH, Lung, Sclerosing hemangioma",
author = "Giuliana Sartori and Stefania Bettelli and Laura Schirosi and Nazzarena Bigiani and Antonio Maiorana and Alberto Cavazza and Giulio Rossi",
year = "2007",
month = "10",
doi = "10.1097/PAS.0b013e318032c8cc",
language = "English",
volume = "31",
pages = "1512--1520",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Microsatellite and EGFR, HER2 and K-RAS analyses in sclerosing hemangioma of the lung

AU - Sartori, Giuliana

AU - Bettelli, Stefania

AU - Schirosi, Laura

AU - Bigiani, Nazzarena

AU - Maiorana, Antonio

AU - Cavazza, Alberto

AU - Rossi, Giulio

PY - 2007/10

Y1 - 2007/10

N2 - Sclerosing hemangioma (SH) is an uncommon pulmonary tumor thought to derive from primitive respiratory epithelium consisting of 2 cell populations (cuboidal surface and polygonal stromal cells) and sharing some clinical characteristics (frequent occurrence in nonsmoking women of Asian ethnicity) with bronchioloalveolar carcinoma with which it has been suggested a possible common origin. We investigated 11 cases of SH by immunohistochemistry, fluorescence in situ hybridization, and polymerase chain reaction-based microsatellite and mutational analyses with particular emphasis on possible alterations of microsatellite loci located at tumor suppressor genes (FHIT, p16, Rb, and p53) involved in lung adenocarcinoma genesis and EGFR, HER2, and K-RAS genes. Although EGFR expression was observed in all tested cases, none showed HER2 immunostaining. Fluorescence in situ hybridization and mutational analysis of EGFR and HER2 and also K-RAS sequencing did not reveal molecular alterations, whereas allelic losses at p16 and Rb loci (4 and 2 out of 9 tested cases, respectively) with an identical microsatellite allelic loss pattern in both cuboidal and polygonal cells were observed. The finding of microsatellite alterations in chromosomal regions related to genes deeply involved in early stage lung adenocarcinoma could suggest a possible link between SH and bronchioloalveolar carcinoma, but tumor pathway promoted by EGFR, HER2, and K-RAS does not represent a common molecular mechanism of tumorigenesis. Microsatellite alterations identified in cuboidal and polygonal cells further confirm the clonal and neoplastic nature of both components of SH.

AB - Sclerosing hemangioma (SH) is an uncommon pulmonary tumor thought to derive from primitive respiratory epithelium consisting of 2 cell populations (cuboidal surface and polygonal stromal cells) and sharing some clinical characteristics (frequent occurrence in nonsmoking women of Asian ethnicity) with bronchioloalveolar carcinoma with which it has been suggested a possible common origin. We investigated 11 cases of SH by immunohistochemistry, fluorescence in situ hybridization, and polymerase chain reaction-based microsatellite and mutational analyses with particular emphasis on possible alterations of microsatellite loci located at tumor suppressor genes (FHIT, p16, Rb, and p53) involved in lung adenocarcinoma genesis and EGFR, HER2, and K-RAS genes. Although EGFR expression was observed in all tested cases, none showed HER2 immunostaining. Fluorescence in situ hybridization and mutational analysis of EGFR and HER2 and also K-RAS sequencing did not reveal molecular alterations, whereas allelic losses at p16 and Rb loci (4 and 2 out of 9 tested cases, respectively) with an identical microsatellite allelic loss pattern in both cuboidal and polygonal cells were observed. The finding of microsatellite alterations in chromosomal regions related to genes deeply involved in early stage lung adenocarcinoma could suggest a possible link between SH and bronchioloalveolar carcinoma, but tumor pathway promoted by EGFR, HER2, and K-RAS does not represent a common molecular mechanism of tumorigenesis. Microsatellite alterations identified in cuboidal and polygonal cells further confirm the clonal and neoplastic nature of both components of SH.

KW - EGFR

KW - K-RAS

KW - LOH

KW - Lung

KW - Sclerosing hemangioma

UR - http://www.scopus.com/inward/record.url?scp=34748880057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34748880057&partnerID=8YFLogxK

U2 - 10.1097/PAS.0b013e318032c8cc

DO - 10.1097/PAS.0b013e318032c8cc

M3 - Article

C2 - 17895751

AN - SCOPUS:34748880057

VL - 31

SP - 1512

EP - 1520

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 10

ER -